Catalano et al. [94] assessed PDE5 expression in breast cancer cell lines and found higher expression in HER2-overexpressing (SKBR3) and basal-like (BT-20/MDA-MB-468/MDA-MB-435) lines, suggesting a correlation between PDE5 expression and more aggressive disease. The gene discussed is PDE5A; the disease is breast carcinoma.